Table 1 Patient Demographics of cancer cohort at time of recruitment
From: Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours
Characteristic | N (%) or median (interquartile range) | |
|---|---|---|
Endometrial cancer cohort | Ovarian cancer cohort | |
Age (year) | 70 (57-77) | 63 (52-69) |
Histological subtype | ||
Endometrioid | 24 (59) | 3 (12) |
Serous | 6 (15) | 15 (58) |
Clear cell | 5 (12) | 1 (4) |
Squamous cell | - | 1 (4) |
Carcinosarcoma | 4 (10) | - |
Adenocarcinoma NOS | - | 1 (4) |
Not recorded | 2 (5) | 2 (8) |
Grade | ||
Borderline | - | 3 (12) |
G1 | 14 (34) | 4 (15) |
G2 | 10 (24) | 3 (12) |
G3 | 17 (41) | 16 (62) |
FIGO stage | ||
I | 29 (71) | 8 (31) |
II | 4 (10) | 4 (15) |
III | 7 (17) | 10 (38) |
IV | 1 (2) | 1 (4) |
Not recorded | - | 3 (12) |